Jennifer Siegel | MGSH
Jennifer serves as hospital counsel for MedStar Franklin Square Medical Center, MedStar Good Samaritan Hospital, and MedStar Union Memorial Hospital. In this role, Jennifer provides legal and regulatory guidance on matters for each hospital, including, but not limited to, those pertaining to patient care and the medical staff, employment, governance, the 340B program, and telehealth.
In addition to serving as hospital counsel for all three Baltimore hospitals, she supports MedStar Health’s 340B Federal discount pharmaceutical program and MedStar Health’s Workplace Violence Prevention Committee.
Before joining MedStar Health in 2021, Jennifer practiced health law at King & Spalding, a reputable law firm with offices worldwide.
Jennifer received her law degree from the University of Maryland School of Law and a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health (with a concentration in infectious disease). She earned her Bachelor of Science in Brain, Behavior, and Cognitive Science from the University of Michigan. She is an active member of the DC and California bars and has recently authored several publications regarding COVID-19 vaccine reimbursement and telehealth expansion after the public health emergency.
In addition to serving as hospital counsel for all three Baltimore hospitals, she supports MedStar Health’s 340B Federal discount pharmaceutical program and MedStar Health’s Workplace Violence Prevention Committee.
Before joining MedStar Health in 2021, Jennifer practiced health law at King & Spalding, a reputable law firm with offices worldwide.
Jennifer received her law degree from the University of Maryland School of Law and a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health (with a concentration in infectious disease). She earned her Bachelor of Science in Brain, Behavior, and Cognitive Science from the University of Michigan. She is an active member of the DC and California bars and has recently authored several publications regarding COVID-19 vaccine reimbursement and telehealth expansion after the public health emergency.